BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 290 filers reported holding BIONTECH SE in Q1 2022. The put-call ratio across all filers is 1.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,848,449 | -24.6% | 63,038 | -25.1% | 0.01% | -16.7% |
| Q2 2023 | $9,085,439 | -14.2% | 84,179 | -1.0% | 0.01% | -14.3% |
| Q1 2023 | $10,592,562 | -67.3% | 85,033 | -60.6% | 0.01% | -73.1% |
| Q4 2022 | $32,396,444 | -4.4% | 215,660 | -14.2% | 0.03% | +8.3% |
| Q3 2022 | $33,884,000 | -37.8% | 251,228 | -31.2% | 0.02% | -41.5% |
| Q2 2022 | $54,454,000 | -38.3% | 365,214 | -29.4% | 0.04% | -24.1% |
| Q1 2022 | $88,225,000 | -48.8% | 517,269 | -22.6% | 0.05% | -41.3% |
| Q4 2021 | $172,268,000 | +12.6% | 668,224 | +19.2% | 0.09% | +2.2% |
| Q3 2021 | $153,028,000 | +18.6% | 560,557 | -2.7% | 0.09% | +16.9% |
| Q2 2021 | $129,007,000 | +156.8% | 576,232 | +25.3% | 0.08% | +140.6% |
| Q1 2021 | $50,227,000 | -22.4% | 459,987 | -42.0% | 0.03% | -17.9% |
| Q4 2020 | $64,689,000 | +26966.5% | 793,541 | +22881.2% | 0.04% | – |
| Q3 2020 | $239,000 | +25.1% | 3,453 | +20.6% | 0.00% | – |
| Q2 2020 | $191,000 | – | 2,864 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 1,053,640 | $179,709,000 | 15.52% |
| Bill & Melinda Gates Foundation | 148,674 | $25,400,000 | 13.66% |
| Baader Bank Aktiengesellschaft | 224,800 | $38,342,000 | 3.07% |
| Quinn Opportunity Partners LLC | 402,239 | $68,606,000 | 2.96% |
| Pendal Group Ltd | 1,957,594 | $333,887,000 | 2.75% |
| Boston Common Asset Management, LLC | 280,181 | $47,788,000 | 2.06% |
| Tri Locum Partners LP | 30,923 | $5,274,000 | 2.06% |
| Renaissance Capital LLC | 25,267 | $4,310,000 | 1.83% |
| Robbins Farley | 13,220 | $2,255,000 | 1.70% |
| APEIRON CAPITAL Ltd | 21,300 | $3,633,000 | 1.61% |